Introduction

47
Poly (lactic-co-glycolic acid) (PLGA) based parenteral formulations are widely used for 48 sustained delivery of various therapeutic entities such as small molecules, peptides as well as 49 proteins [1] [2] [3] . There are currently twelve PLGA/PLA based microsphere products available on 50 the market, including Risperdal® Consta®, Sandostatin® LAR, Zoladex®, and Lupron Depot®.
51
This type of formulation is suitable for achieving long-term efficacy with reduced dosing 52 frequency and is typically administered via the intramascular (I.M.) and subcutaneous (S.C.) 53 routes. It is critical to understand the drug release mechanism from microspheres in order to 54 design and develop formulations with controlled release kinetics. Diffusion and 55 degradation/erosion are two main release mechanisms associated with this type of formulation.
56
The initial phase of drug release is usually considered to be controlled by drug diffusion from the 57 surface and the later stage of drug release is associated with degradation and erosion [4] .
58
Hydration takes place with great speed relative to erosion when the microspheres are immersed 59 in an aqueous buffer. Microsphere hydration is followed by polymer chain degradation which 60 occurs throughout the polymer matrix in the form of random hydrolysis and leads to the 61 formation of internal pores [5] . compositions [7] . Such heterogeneity can be partly attributed to a pH gradient from the interior 68 (low pH) to the surface (high pH) of the microspheres, due to accumulation of hydrolyzed 69 lactic/glycolic acid monomers and oligomers within the microspheres [8, 9] . This occurs as a 70 result of the slower diffusion of lactic/glycolic acid monomers and oligomers compared to buffer 71 components [8] . An often neglected fact is that water diffusion from the outside to the inside 72 (swelling) due to the increased osmotic pressure can lead to a higher degree of dilution of the 73 acidic components close to the surface. Swelling is an important process during PLGA 74 microsphere degradation. Initial microsphere swelling has been reported to form a skin layer on 75 the surface as a result of pore-closing [10] and therefore delay the initial drug release which may 76 cause an apparent lag phase. Initial microsphere swelling has also been reported to cause burst 77 4 release [11] . Swelling and water uptake in clonidine-loaded PLGA microspheres during the 78 second drug release phase was reported by Gaignaux et al[12] . However, the method used by 79 these researchers which involved measuring filtered wet microspheres may have resulted in 80 significant error due to adsorbed water on the microsphere surfaces. More recent findings have 81 indicated that microsphere swelling with significant volume increase coincides with the onset of 82 the second drug burst release phase [13, 14] . Microsphere swelling is possibly a result of 83 polymer chain relaxation due to elevated temperature and increased osmotic pressure resulting 84 from accumulation of dissolved drug and degradation species [15] . Unfortunately, the water 85 uptake into these microspheres was not reported in these studies.
86
The microsphere internal structure may significantly affect drug release. In protein loaded 87 microspheres prepared using the double emulsion-solvent evaporation method, pore closing and 88 opening events were observed to affect drug release [10, 16] [10, 16, 19, 20] . This sample preparation process may 97 create defects which may alter the internal structure of the particles. Accordingly, low 98 temperature scanning electron microscopy (cryo-SEM) may be a better technique to investigate 99 microsphere internal structure since the samples are flash-frozen in liquid nitrogen and then 100 freeze-fractured to maintain the structural characteristics for imaging. This technique has been 101 successfully used for biological samples [21] . To the best of our knowledge, cryo-SEM has never 102 been used to investigate PLGA microsphere internal structure changes. were dispersed in 1 mL 5% (w/w) PVA solutions (133 KDa) and the dispersions were filled into dexamethasone in each sample was determined using the HPLC method as described above. The same test was repeated at pre-determined time points and the microdialysis probes were the medium external to the dialysis probe at the specified time points (t). 
Low temperature scanning electron microscopy (cryo-SEM)
225
In order to investigate the internal structure change of composite coatings, cryo-SEM was 226 performed to evaluate the samples after incubation in PBS at 37 ˚C after specified time points.
227
Samples of ~ 1 mm 3 size were mounted onto standard specimen carriers (for the EM VCT100 
319
In order to further investigate the effect of microsphere swelling and degradation on glucose 320 diffusion through the composite coating, glucose RR was also tested for coatings prepared using 
362
Cryo-SEM was also performed on PLGA microsphere/PVA hydrogel composites prepared using increased from day 6 to day 9 (from approximately 240±138 nm to approximately 367±197 nm).
368
Minor internal structure deformation was observed at day 9 (Figure 8-F) . Starting from day 12, property of these hydrogels has been thoroughly investigated [32, 33] . They usually reach 392 swelling equilibrium within a few hours which is consistent with the results reported here for the 393 hydrogels alone and those loaded with the RG503H microspheres (Figure 3 ). In the case of the 394 hydrogels containing the DLG1A microspheres, a fast hydrogel equilibration period was not 395 observed and this is probably due to masking by the rapid swelling of these microspheres.
396
The long-term swelling properties of the PLGA microsphere/PVA hydrogel composites has not phase of RG503H microspheres and persisted during the remainder of the drug release period.
401
Although a significant particle size change has been reported for PLGA microspheres at the 402 onset of the second rapid drug release phase, the water uptake was not quantified in this study
403
[14]. In the current study, we were able to quantify the amount of water uptake by the 404 microspheres as they were embedded in the PVA hydrogels and the hydrogels only absorbed 
411
For both microspheres, the maximum amount of water uptake ranges from 2 to 3 times their 412 weight (Table 2) .
413 Table 2 Calculated maximum swelling ratio of microspheres embedded in the composite release profile indicates that the RG503H microspheres follow a bulk erosion mechanism.
426
The burst release of drug from microspheres is usually considered to be a result of surface drug out of the microspheres and disturbing the intrinsic gel structure during the burst release phase.
430
The coincidence between the drug release profile and water uptake for both microsphere 
454
The surface layer of the microspheres is exposed to water earlier and therefore starts to degrade 
483
In the current study, a positive correlation was observed using a plot between the RR and 484 swelling ratio at 3 hours while a negative correlation was observed at maximum swelling date to freely pass through the holes that were earlier occupied by the microspheres. In addition, 500 decrease in water uptake was observed post the second drug release phase indicating that the 501 coating was shrinking (decreasing in thickness) with the disappearance of the microsphere shells. 
Conclusion
506
The present study demonstrated new insights into PGLA microsphere drug release mechanisms applications. The information generated in this study on the dynamic internal changes in the 522 microspheres will also be useful in understanding drug stability during the release process.
523
Furthermore, the correlation between microsphere swelling and glucose permeation through the 524 coatings will facilitate coating design for glucose sensors and other similar implantable devices. Red arrows point at the microspheres at low magnification, red triangles point at the microspheres at medium/high magnification, green squares point at the hydrogel at medium/high magnification and white arrows point at the interphase between the microsphere and the PVA hydrogel.
Figure 8. Cryo-SEM images showing the internal structure of the PLGA microsphere/PVA hydrogel composites (prepared using the RG503H polymer) following incubation in phosphate buffer for 3h, 5h, 1 day, 2 days, 4 days, 9 days, 12 days and 15 days (corresponding to A, B, C, D, E, F, G, H, respectively). The red triangles point at the microspheres, the green squares point at the hydrogel, the white arrows point at the interphase between microsphere and PVA hydrogel, and the yellow arrows point at the deformation/collapse of the porous structure. I shows particle size change over time obtained by analyzing low magnification images (approximately 1000X, data not shown) following 5h, 6 day and 15 day incubation. Approximately 100 particles were analyzed for each image.* indicates statistical significance analyzed using paired student t-test (p<0.001) Figure 9 . Correlation between coating swelling ratio and RR of glucose through the coatings prepared with RG503H microspheres following 3 hours (A) and 24 days (B) incubation. 
